Vasa Therapeutics
PrivateLast Round
Seed
Jan 3, 2024
Total Funding Raised
$11M
Company Overview
Vasa Therapeutics operates in Healthcare & Life Sciences and is based in Encinitas, California. Its latest recorded funding round was a Seed round in January 2024.
Vasa Therapeutics is a biopharmaceutical company that discovers and develops therapeutics targeting the pathophysiology of cardiovascular aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vasa Therapeutics Comparables
Compare Vasa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CardiaTec | 88% | |
| Antlia Bioscience, Inc. | 73% | |
| POLYGON Therapeutics | 72% |
For institutional investors. Book with your work email.
Vasa Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vasa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SeedFolio | Seed |
| Orphinic Scientific SA | Seed |
| NuFund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Partnered with Eli Lilly's 'tunelab' for AI/ML platform.
- Feb 12, 2026
Attended the 36th Annual Oppenheimer Life Sciences Conference.
For institutional investors. Book with your work email.
Vasa Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vasa Therapeutics's valuation, stock price, and market status.
Is Vasa Therapeutics a public or private company?
Vasa Therapeutics is a private company.
What is the current stock price of Vasa Therapeutics?
Vasa Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vasa Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vasa Therapeutics worth (valuation)?
Valuation information for Vasa Therapeutics is not publicly available.
Can I buy Vasa Therapeutics stock?
Vasa Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vasa Therapeutics's last funding round?
Vasa Therapeutics's most recent funding round was Seed on January 3, 2024.
Who are the main investors in Vasa Therapeutics?
Key investors in Vasa Therapeutics include Orphinic Scientific SA.
Will Vasa Therapeutics IPO soon?
No public IPO plans have been announced for Vasa Therapeutics.
How can I track Vasa Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vasa Therapeutics's shares on secondary markets.